GHK-Cu Peptide Research: Mechanisms & Preclinical Data
Preclinical research overview of GHK-Cu, a naturally occurring copper-binding tripeptide first isolated from human plasma in 1973. Covers gene expression modulation, tissue remodeling models, anti-inflammatory signaling, and oxidative stress pathways. HPLC-verified at 99.81% purity. For laboratory research use only.
MOTS-c: The Mitochondrial-Derived Peptide Under Investigation for Metabolic Regulation
A research overview of MOTS-c, the 16-amino-acid peptide encoded by mitochondrial DNA. Covers metabolic regulation, exercise adaptation, aging, and cardiovascular research with 10 verified PubMed citations.
TB-500: Preclinical Research Overview
TB-500 (Thymosin Beta-4) is a synthetic peptide derived from a naturally occurring protein found in virtually all human and animal cells. Preclinical research has examined its role in actin regulation, cellular migration, and tissue repair across a range of in vitro and animal model studies. This overview summarizes the current state of laboratory findings on TB-500 — for research and informational purposes only.
BPC-157 Research Overview: What Laboratory Studies Have Been Examined So Far
A research overview of BPC-157, a synthetic pentadecapeptide studied in preclinical models. Covers laboratory findings, FDA Category 2 classification, and storage requirements for research-grade BPC-157.